Serum Phosphate Is Associated With Fracture Risk: The Rotterdam Study and MrOS

被引:47
作者
Campos-Obando, Natalia [1 ]
Koek, W. Nadia H. [1 ]
Hooker, Elizabeth R. [2 ]
van der Eerden, Bram C. J. [1 ]
Pols, Huibert A. [1 ,3 ]
Hofman, Albert [3 ]
van Leeuwen, Johannes P. T. M. [1 ]
Uitterlinden, Andre G. [1 ,3 ]
Nielson, Carrie M. [2 ,4 ]
Zillikens, M. Carola [1 ,3 ]
机构
[1] Erasmus MC, Dept Internal Med, POB 2040, NL-3000 CA Rotterdam, Netherlands
[2] Oregon Hlth & Sci Univ, Bone & Mineral Unit, Portland, OR 97201 USA
[3] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
[4] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA
基金
美国国家卫生研究院;
关键词
PHOSPHATE LEVELS; FRACTURES; BMD; CALCIUM; 25-HYDROXYVITAMIN D; BONE-MINERAL DENSITY; GROWTH-FACTOR; 23; OSTEOPOROTIC FRACTURES; OLDER MEN; HIP FRACTURE; VASCULAR CALCIFICATION; 25-HYDROXYVITAMIN D; PHOSPHORUS; HEALTH; FGF23;
D O I
10.1002/jbmr.3094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Extreme phosphate levels (P) have been associated with mineralization defects and increased fracture risk. Whether P within normal range is related to bone health in the general population is not well understood. To investigate the association of P with bone mineral density (BMD) and fracture risk, we assessed two population-based cohorts: the Dutch Rotterdam Study (RS-I, RS-II, RS-III; n = 6791) and the US Osteoporotic Fractures in Men (MrOS; n = 5425) study. The relationship of P with lumbar spine (LS) and femoral neck (FN) BMD was tested in all cohorts via linear models; fracture risk was tested in RS-I, RS-II, and MrOS through Cox models, after follow-up of 8.6, 6.6, and 10.9 years, respectively. Adjustments were made for age, body mass index, smoking, serum levels of calcium, potassium, 25-hydroxyvitamin D, estimated glomerular filtration rate (eGFR), FN-BMD, prevalent diabetes, and cardiovascular disease. Additional adjustments were made for phosphate intake, parathyroid hormone, and fibroblast growth factor 23 levels in MrOS. We further stratified by eGFR. Results were pooled through study-level metaanalyses. Hazard ratios (HR) and betas (b) (from meta-analyses) are expressed per 1mg/dL P increase. P was positively associated with fracture risk in men and women from RS, and findings were replicated in MrOS (pooled HR all [95% CI]: 1.47 [1.31-1.65]). P was associated with fracture risk in subjects without chronic kidney disease (CKD): all (1.44 [1.26-1.63]) and in men with CKD (1.93 [1.42-2.62]). P was inversely related to LS-BMD in men (b: -0.06 [-0.11 to -0.02]) and not to FN-BMD in either sex. In summary, serum P was positively related to fracture risk independently from BMD and phosphate intake after adjustments for potential confounders. P and LS-BMD werenegatively related in men. Our findings suggest that increased P levels even within normal range might be deleterious for bone health in the normal population. (C) 2017 American Society for Bone and Mineral Research.
引用
收藏
页码:1182 / 1193
页数:12
相关论文
共 70 条
[1]  
Akaike H., 1976, MATH SCI, V14, P5
[2]  
Albright F, 1937, AM J DIS CHILD, V54, P529
[3]  
Amato D, 1998, REV INVEST CLIN, V50, P185
[4]  
[Anonymous], END ABSTR
[5]   Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study [J].
Barrett-Connor, Elizabeth ;
Nielson, Carrie M. ;
Orwoll, Eric ;
Bauer, Douglas C. ;
Cauley, Jane A. .
BRITISH MEDICAL JOURNAL, 2010, 340 :798
[6]  
Bauer DC, 2009, J BONE MINER RES, V24, P2032, DOI [10.1359/JBMR.090526, 10.1359/jbmr.090526]
[7]   Chronic Kidney Disease Progression and Outcome According to Serum Phosphorus in Mild-to-Moderate Kidney Dysfunction [J].
Bellasi, Antonio ;
Mandreoli, Marcora ;
Baldrati, Leopoldo ;
Corradini, Matteo ;
Di Nicolo, Pierpaolo ;
Malmusi, Giulio ;
Santoro, Antonio .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (04) :883-891
[8]   CONSEQUENCES OF PHOSPHATE IMBALANCE [J].
BERNER, YN ;
SHIKE, M .
ANNUAL REVIEW OF NUTRITION, 1988, 8 :121-148
[9]   A Study to Inform the Design of a National Multicentre Randomised Controlled Trial to Evaluate If Reducing Serum Phosphate to Normal Levels Improves Clinical Outcomes including Mortality, Cardiovascular Events, Bone Pain, or Fracture in Patients on Dialysis [J].
Bhargava, Ramya ;
Kalra, Philip A. ;
Brenchley, Paul ;
Hurst, Helen ;
Hutchison, Alastair .
INTERNATIONAL JOURNAL OF NEPHROLOGY, 2015, 2015
[10]   Overview of recruitment for the osteoporotic fractures in men study (MrOS) [J].
Blank, JB ;
Cawthon, PM ;
Carrion-Petersen, ML ;
Harper, L ;
Johnson, JP ;
Mitson, E ;
Delay, RR .
CONTEMPORARY CLINICAL TRIALS, 2005, 26 (05) :557-568